Back
Speaker illustration

undefined undefined undefined

Presentations

May oral anticoagulation be considered for secondary prevention after coronary artery bypass operation complicated with postoperative atrial fibrillation in a high-risk patient?

Event: ESC Congress 2022

Topic: Clinical

Session: Atrial fibrillation

Access
Like
Thumbnail

Immediate implementation of three 2019 european society of cardiology guidelines in daily practice

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipids

Session: Risk Factors and Prevention ePosters

Access
Like
Thumbnail

Secondary prophylaxis after cardiogenic shock in a 47-years old man presenting with STEMI with positive family history for sudden cardiac death (father) and very high Lp(a) as single cardiovascular risk factor.

Event: Heart Failure 2021

Topic: Clinical

Session: Clinical Case session

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources